鎮痛薬市場：薬物タイプ、種類、投与経路、流通別-2025-2030年の世界予測

鎮痛薬市場は、2023年に218億5,000万米ドルと評価され、2024年には237億5,000万米ドルに達すると予測され、CAGR 8.79％で成長し、2030年には394億2,000万米ドルに達すると予測されています。

鎮痛薬市場には、アセトアミノフェンやイブプロフェンのような市販薬から処方オピオイドや高度な製剤まで、幅広い鎮痛薬が含まれます。鎮痛薬は、慢性疾患、術後の回復、急性の怪我など、様々な症状による痛みを和らげるためにヘルスケアに不可欠です。その用途は、病院、クリニック、小売薬局、在宅医療など様々な場面で広がり、個人消費者から医療従事者まで多様なエンドユーザーにサービスを提供しています。鎮痛薬市場の成長を牽引しているのは、慢性疾患の蔓延、高齢者人口の増加、非侵襲的疼痛管理ソリューションに対する需要の高まりです。個別化医療の発展、ドラッグデリバリーシステムの進歩、非オピオイド鎮痛薬への注目の高まりといった新たな動向は、大きな成長機会を提供します。しかし、市場は規制当局の監視、オピオイドに関連する中毒リスク、ジェネリック医薬品の市場飽和といった課題に直面しています。企業は、製剤の革新に注力し、相乗効果のある提携関係を模索することで、こうした課題を乗り切ることができます。天然成分や植物由来成分の研究開発への資金提供の増加は、差別化を図り、健康志向の消費者にアピールするための有効な機会となります。さらに、スマートウェアラブルやモバイルアプリのようなテクノロジーを活用した疼痛管理ソリューションを模索することで、疼痛管理プロトコルへの関与とアドヒアランスを促進することができます。市場の競争は、戦略的マーケティングと消費者教育の重要性を強調しています。持続的な成長を確保するためには、企業は安全で効果的な非オピオイド製剤への投資を優先し、ヘルスケア水準が向上している新興市場に地理的な足跡を拡大すべきです。このような側面に取り組むことで、企業は世界のヘルスケア市場に積極的に貢献しながら、新たな収益源を確保することができます。

市場力学：急速に進化する鎮痛薬市場の主要市場インサイトを公開

鎮痛薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 心血管疾患（CVD）、がん、関節炎の罹患率の上昇
  • 地域在住の高齢者における定期的な鎮痛治療の有病率の増加
  • 市販鎮痛薬の費用対効果
• 市場抑制要因
  • オピオイドの無秩序な処方と薬物乱用
• 市場機会
  • 官民による研究開発投資の増加
  • 個別化医療の人気の高まり
• 市場の課題
  • オピオイドを含む有効性の高い医薬品の入手可能性と価格の制限鎮痛薬

ポーターの5つの力鎮痛薬市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：鎮痛薬市場における外部からの影響の把握

外部マクロ環境要因は、鎮痛薬市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析鎮痛薬市場における競合情勢の把握

鎮痛薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス鎮痛薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、鎮痛薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨鎮痛薬市場における成功への道筋を描く

鎮痛薬市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 心血管疾患（CVD）、がん、関節炎の発生率の上昇
    • 地域在住の高齢者における定期的な鎮痛治療の普及率が上昇している
    • 市販鎮痛薬の費用対効果
  • 抑制要因
    • オピオイドの無秩序な処方と薬物乱用
  • 機会
    • 官民による研究開発への投資増加
    • 個別化医療の人気の高まり
  • 課題
    • オピオイドを含む高効能薬の入手性と価格が限られている鎮痛薬
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 鎮痛薬市場薬の種類別

• アセトアミノフェン
• 非ステロイド性抗炎症薬
• サリチル酸塩

第7章 鎮痛薬市場：タイプ別

• 非オピオイド
• オピオイド

第8章 鎮痛薬市場：投与経路別

• 静脈内
• オーラル
• 直腸
• 話題
• 経皮

第9章 鎮痛薬市場配布元

• 病院薬局
• オンライン薬局
• 小売薬局

第10章 南北アメリカの鎮痛薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の鎮痛薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの鎮痛薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AbbVie Inc.
• Assertio Therapeutics, Inc.
• Bausch Health Companies Inc.
• Baxter International Inc.
• Bayer AG
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb Company
• Eli Lilly and Company
• Endo Pharmaceuticals Inc.
• Glaxosmithkline PLC
• Johnson & Johnson Services, Inc.
• Novartis AG
• Pfizer Inc.
• Purdue Pharmaceuticals L.P.
• Reckitt Benckiser Group PLC
• Sun Pharmaceutical Industries, Inc.
• Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

• FIGURE 1. ANALGESICS MARKET RESEARCH PROCESS
• FIGURE 2. ANALGESICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ANALGESICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ANALGESICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ANALGESICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ANALGESICS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ANALGESICS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ANALGESICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ANALGESICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS ANALGESICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS ANALGESICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES ANALGESICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES ANALGESICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. ANALGESICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. ANALGESICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ANALGESICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ANALGESICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ANALGESICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ANALGESICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ANALGESICS MARKET DYNAMICS
• TABLE 7. GLOBAL ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ANALGESICS MARKET SIZE, BY ACETAMINOPHEN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ANALGESICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ANALGESICS MARKET SIZE, BY SALICYLATES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ANALGESICS MARKET SIZE, BY NON-OPIOIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ANALGESICS MARKET SIZE, BY OPIOIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ANALGESICS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ANALGESICS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ANALGESICS MARKET SIZE, BY RECTAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ANALGESICS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL ANALGESICS MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL ANALGESICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL ANALGESICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL ANALGESICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS ANALGESICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 37. CANADA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 38. CANADA ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. CANADA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 40. CANADA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES ANALGESICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC ANALGESICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 58. AUSTRALIA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 59. CHINA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 60. CHINA ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. CHINA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 62. CHINA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 63. INDIA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 64. INDIA ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. INDIA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 66. INDIA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 70. INDONESIA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 74. JAPAN ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 78. MALAYSIA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 82. PHILIPPINES ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 86. SINGAPORE ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH KOREA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 94. TAIWAN ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 98. THAILAND ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 102. VIETNAM ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA ANALGESICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 111. DENMARK ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 115. EGYPT ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 119. FINLAND ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 123. FRANCE ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 127. GERMANY ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 131. ISRAEL ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 132. ITALY ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 133. ITALY ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 134. ITALY ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 135. ITALY ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 139. NETHERLANDS ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 143. NIGERIA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 147. NORWAY ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 148. POLAND ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 149. POLAND ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 150. POLAND ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 151. POLAND ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 152. QATAR ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 153. QATAR ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 154. QATAR ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 155. QATAR ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 159. RUSSIA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 171. SPAIN ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 175. SWEDEN ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 179. SWITZERLAND ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 183. TURKEY ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM ANALGESICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM ANALGESICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM ANALGESICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM ANALGESICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 192. ANALGESICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 193. ANALGESICS MARKET, FPNV POSITIONING MATRIX, 2023

The Analgesics Market was valued at USD 21.85 billion in 2023, expected to reach USD 23.75 billion in 2024, and is projected to grow at a CAGR of 8.79%, to USD 39.42 billion by 2030.

The analgesics market encompasses a wide range of pain-relieving medications, from over-the-counter options like acetaminophen and ibuprofen to prescription opioids and advanced formulations. Analgesics are essential in healthcare for alleviating pain from various conditions, such as chronic illnesses, post-surgical recovery, and acute injuries. Their application extends across multiple settings, including hospitals, clinics, retail pharmacies, and home care, serving diverse end-users ranging from individual consumers to healthcare providers. Growth in the analgesics market is driven by increased prevalence of chronic diseases, rising geriatric population, and growing demand for non-invasive pain management solutions. Emerging trends such as the development of personalized medicine, advancements in drug delivery systems, and the rising focus on non-opioid analgesics offer significant growth opportunities. However, the market faces challenges from regulatory scrutiny, addiction risks associated with opioids, and market saturation of generic medications. Companies can navigate these challenges by focusing on innovation in drug formulation and exploring synergistic partnerships for broadened reach. Increased funding into R&D for natural and plant-based analgesics presents a viable opportunity for differentiation and appeal to health-conscious consumers. Moreover, exploring pain management solutions powered by technology, like smart wearables and mobile apps, can drive engagement and adherence in pain management protocols. The market's competitive nature emphasizes the importance of strategic marketing and consumer education to highlight the benefits and safety of new analgesic products. To ensure sustainable growth, businesses should prioritize investments in safe, effective non-opioid formulations and expand their geographical footprints to emerging markets with rising healthcare standards. By addressing these aspects, companies can unlock new revenue streams while contributing positively to global healthcare markets.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Analgesics Market

The Analgesics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising incidences of cardiovascular disease (CVD), cancer, & arthritis
  • Prevalence of regular analgesic treatment has increased among community-dwelling older person
  • Cost-effectiveness of over-the-counter analgesic medications
• Market Restraints
  • Uncontrolled prescriptions of opioids and drug abuse
• Market Opportunities
  • Increasing investments in R&D by the public & private sectors
  • Surge in popularity of personalized medicine
• Market Challenges
  • Limited availability and affordability of high efficacy drugs, including opioid analgesics

Porter's Five Forces: A Strategic Tool for Navigating the Analgesics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Analgesics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Analgesics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Analgesics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Analgesics Market

A detailed market share analysis in the Analgesics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Analgesics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Analgesics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Analgesics Market

A strategic analysis of the Analgesics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Analgesics Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Assertio Therapeutics, Inc., Bausch Health Companies Inc., Baxter International Inc., Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, Endo Pharmaceuticals Inc., Glaxosmithkline PLC, Johnson & Johnson Services, Inc., Novartis AG, Pfizer Inc., Purdue Pharmaceuticals L.P., Reckitt Benckiser Group PLC, Sun Pharmaceutical Industries, Inc., and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Analgesics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Drug Type, market is studied across Acetaminophen, Nonsteroidal Anti-Inflammatory Drugs, and Salicylates.
• Based on Type, market is studied across Non-Opioids and Opioids.
• Based on Route of Administration, market is studied across Intravenous, Oral, Rectal, Topical, and Transdermal.
• Based on Distribution, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidences of cardiovascular disease (CVD), cancer, & arthritis
    • 5.1.1.2. Prevalence of regular analgesic treatment has increased among community-dwelling older person
    • 5.1.1.3. Cost-effectiveness of over-the-counter analgesic medications
  • 5.1.2. Restraints
    • 5.1.2.1. Uncontrolled prescriptions of opioids and drug abuse
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing investments in R&D by the public & private sectors
    • 5.1.3.2. Surge in popularity of personalized medicine
  • 5.1.4. Challenges
    • 5.1.4.1. Limited availability and affordability of high efficacy drugs, including opioid analgesics
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Analgesics Market, by Drug Type

• 6.1. Introduction
• 6.2. Acetaminophen
• 6.3. Nonsteroidal Anti-Inflammatory Drugs
• 6.4. Salicylates

7. Analgesics Market, by Type

• 7.1. Introduction
• 7.2. Non-Opioids
• 7.3. Opioids

8. Analgesics Market, by Route of Administration

• 8.1. Introduction
• 8.2. Intravenous
• 8.3. Oral
• 8.4. Rectal
• 8.5. Topical
• 8.6. Transdermal

9. Analgesics Market, by Distribution

• 9.1. Introduction
• 9.2. Hospital Pharmacies
• 9.3. Online Pharmacies
• 9.4. Retail Pharmacies

10. Americas Analgesics Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Analgesics Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Analgesics Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AbbVie Inc.
• 2. Assertio Therapeutics, Inc.
• 3. Bausch Health Companies Inc.
• 4. Baxter International Inc.
• 5. Bayer AG
• 6. Boehringer Ingelheim International GmbH
• 7. Bristol-Myers Squibb Company
• 8. Eli Lilly and Company
• 9. Endo Pharmaceuticals Inc.
• 10. Glaxosmithkline PLC
• 11. Johnson & Johnson Services, Inc.
• 12. Novartis AG
• 13. Pfizer Inc.
• 14. Purdue Pharmaceuticals L.P.
• 15. Reckitt Benckiser Group PLC
• 16. Sun Pharmaceutical Industries, Inc.
• 17. Teva Pharmaceutical Industries Ltd.